| Literature DB >> 31221998 |
Risa Sato1, Hiroshi Kunikata2,3, Toshifumi Asano1, Naoko Aizawa1, Naoki Kiyota1, Yukihiro Shiga1, Koji M Nishiguchi4, Keiichi Kato5, Toru Nakazawa1,6,4,7.
Abstract
This study evaluated age-related changes in the superficial and deep retinal capillary plexus (SCP and DCP, respectively) and in the foveal avascular zone (FAZ). SCP and DCP perfusion density (PD) were measured in optical coherence tomography angiography (OCTA) macular scans of 145 eyes of 145 healthy Japanese subjects, and findings were compared with SCP FAZ and clinical data. We found that age was negatively correlated with SCP and DCP PD (r = -0.17, P = 0.04 and r = -0.20, P = 0.02, respectively) and positively correlated with FAZ area (r = 0.18, P = 0.03). SCP and DCP PD were correlated with each other (r = 0.67, P < 0.001). FAZ area was negatively correlated with SCP PD, DCP PD and central macular thickness (CMT) (r = -0.18, P = 0.03; r = -0.25, P < 0.01; and r = -0.39, P < 0.001, respectively). FAZ was larger and CMT was lower (P = 0.01 and P < 0.001, respectively) in women than men. SCP and DCP PD were positively correlated with estimated glomerular filtration rate (r = 0.17, P = 0.03 and r = 0.24, P < 0.01, respectively). Multiple regression analysis confirmed that age independently affected DCP PD and FAZ (P = 0.02 and P < 0.01, respectively) and that CMT independently affected FAZ area (P < 0.001). Thus, normal subjects showed age-related decreases in macular PD and renal function. FAZ and CMT were related, suggesting that age-related changes in macular thickness also affect capillary vasculature.Entities:
Mesh:
Year: 2019 PMID: 31221998 PMCID: PMC6586606 DOI: 10.1038/s41598-019-45336-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristics of eyes divided by age.
| All | 30–39 YO | 40–49 YO | 50–59 YO | 60–74 YO | ||
|---|---|---|---|---|---|---|
|
| ||||||
| Number of eyes | 145 | 47 | 13 | 14 | 71 | — |
| Sex (male: female) | 45:100 | 10:37 | 6:7 | 5:9 | 24:47 | 0.28a |
| Age (years) | 53.3 ± 14.6 | 34.5 ± 2.6 | 44.4 ± 2.2 | 54.8 ± 3.3 | 66.0 ± 3.6 | — |
|
| ||||||
| SBP (mmHg) | 121.7 ± 15.4 | 113.0 ± 12.7 | 112.4 ± 11.4 | 123.5 ± 15.2 | 128.2 ± 14.4 | <0.001b |
| DBP (mmHg) | 72.9 ± 10.6 | 68.2 ± 9.6 | 71.3 ± 10.7 | 78.6 ± 10.6 | 74.9 ± 10.3 | <0.001b |
| TG (mg/dl) | 109.5 ± 65.0 | 88.6 ± 63.0 | 98.0 ± 52.0 | 124.4 ± 83.7 | 122.6 ± 62.1 | 0.03b |
| AST (IU/L) | 22.0 ± 6.3 | 20.1 ± 6.9 | 19.5 ± 5.0 | 23.3 ± 5.2 | 23.4 ± 6.0 | 0.02b |
| ALT (IU/L) | 19.5 ± 9.7 | 19.7 ± 13.7 | 16.1 ± 5.6 | 21.4 ± 8.1 | 19.5 ± 7.1 | 0.56b |
| γ-GTP (IU/L) | 27.9 ± 28.1 | 29.0 ± 38.7 | 20.0 ± 9.2 | 27.9 ± 18.5 | 28.6 ± 23.6 | 0.77b |
| eGFR (ml/min/1.73 m²) | 82.0 ± 16.5 | 92.9 ± 14.4 | 92.4 ± 13.5 | 77.8 ± 14.1 | 73.7 ± 13.6 | <0.001b |
| HbA1c(%) | 5.7 ± 0.3 | 5.5 ± 0.2 | 5.5 ± 0.2 | 5.8 ± 0.3 | 5.8 ± 0.3 | <0.001b |
|
| ||||||
| Axial length (mm) | 23.9 ± 1.1 | 24.4 ± 1.0 | 24.3 ± 1.2 | 24.1 ± 0.9 | 23.4 ± 0.9 | <0.001b |
| IOP (mmHg) | 13.8 ± 2.2 | 13.9 ± 2.3 | 14.7 ± 2.8 | 13.5 ± 1.2 | 13.5 ± 2.2 | 0.32b |
| CMT (μm) | 295.4 ± 16.5 | 296.0 ± 19.1 | 301.4 ± 14.0 | 293.8 ± 13.0 | 294.2 ± 15.9 | 0.53b |
| Overall SCP PD (%) | 43.6 ± 1.6 | 44.1 ± 1.5 | 43.6 ± 1.9 | 43.3 ± 2.2 | 43.3 ± 1.4 | 0.08b |
| Overall DCP PD (%) | 44.4 ± 2.2 | 45.3 ± 2.0 | 45.0 ± 2.0 | 44.5 ± 2.8 | 43.6 ± 2.0 | <0.01b |
| Parafoveal SCP PD (%) | 48.2 ± 1.7 | 48.4 ± 1.8 | 48.0 ± 2.0 | 47.9 ± 2.4 | 48.2 ± 1.5 | 0.77b |
| Parafoveal DCP PD (%) | 49.9 ± 2.6 | 50.7 ± 2.3 | 50.5 ± 2.6 | 49.8 ± 3.7 | 49.4 ± 2.5 | 0.07b |
| FAZ (mm²) | 0.37 ± 0.1 | 0.33 ± 0.1 | 0.33 ± 0.1 | 0.37 ± 0.1 | 0.39 ± 0.1 | 0.04b |
SBP = systolic blood pressure, DBP = diastolic blood pressure, TG = triglyceride, AST = aspartate aminotransferase.
ALT = alanine aminotransferase, γ-GTP = γ-glutamyl transpeptidase, eGFR = glomerular filtration rate, HbA1c = hemoglobin A1c.
IOP = intraocular pressure, CMT = central macular thickness, SCP = superficial retinal capillary plexus, PD = perfusion density, DCP = deep retinal capillary plexus, FAZ = foveal avascular zone.
aChi-square test.
bOne-way analysis of variance.
Figure 1Diagram showing study design. Out of 924 eyes of 462 subjects, 145 eyes of 145 subjects were carefully selected and included as healthy eyes in this study.
Figure 2SCP and DCP PD and FAZ in the four groups classified by age. There was no significant difference in SCP PD between the four groups (left). DCP PD was lower in the 50–59 YO group and the 60–74 YO group than in the 30–39 YO group (P < 0.01 and P < 0.01, respectively; center). FAZ area in the SCP was larger in the 60–74 YO group than in the 30–39 YO group (P = 0.04; right).
Comparison of SCP and DCP PD in ETDRS-defined areas.
| Overall (%) | Fovea (%) | Parafovea (%) | Temporal (%) | Superior (%) | Nasal (%) | Inferior (%) | |
|---|---|---|---|---|---|---|---|
| All (30–74 YO) | |||||||
| SCP | 43.6 ± 1.6 | 19.4 ± 4.8 | 48.2 ± 1.7 | 47.1 ± 2.7 | 50.9 ± 3.5 | 46.9 ± 2.8 | 48.8 ± 3.3 |
| DCP | 44.4 ± 3.3 | 15.5 ± 4.7 | 50.0 ± 2.6 | 47.4 ± 3.5 | 51.4 ± 4.4 | 49.3 ± 3.7 | 51.7 ± 4.3 |
| | <0.001 | <0.001 | <0.001 | 0.49 | <0.01 | <0.001 | <0.001 |
| 30–39 YO | |||||||
| SCP | 44.1 ± 1.5 | 21.3 ± 4.9 | 48.4 ± 1.8 | 47.3 ± 2.3 | 50.6 ± 3.5 | 47.3 ± 2.5 | 48.5 ± 3.5 |
| DCP | 45.3 ± 2.0 | 17.2 ± 4.6 | 50.7 ± 2.3 | 48.2 ± 3.4 | 52.4 ± 3.5 | 49.8 ± 3.2 | 52.3 ± 4.2 |
| | <0.001 | <0.001 | <0.001 | 0.15 | 0.01 | <0.001 | <0.001 |
| 40–49 YO | |||||||
| SCP | 43.6 ± 1.9 | 20.7 ± 4.5 | 48.0 ± 2.1 | 47.4 ± 2.8 | 48.9 ± 3.1 | 47.3 ± 2.3 | 48.4 ± 2.1 |
| DCP | 45.0 ± 2.0 | 16.5 ± 4.2 | 50.5 ± 2.6 | 48.5 ± 3.2 | 50.5 ± 3.5 | 50.8 ± 2.3 | 52.0 ± 4.1 |
| | 0.08 | 0.02 | 0.02 | 0.36 | 0.26 | <0.01 | 0.02 |
| 50–59 YO | |||||||
| SCP | 43.3 ± 2.2 | 19.0 ± 4.1 | 48.0 ± 2.4 | 46.1 ± 2.9 | 50.0 ± 3.7 | 47.3 ± 3.0 | 48.5 ± 3.5 |
| DCP | 44.5 ± 2.8 | 16.4 ± 5.3 | 49.8 ± 3.7 | 46.4 ± 2.9 | 51.6 ± 5.0 | 49.5 ± 5.0 | 51.8 ± 5.3 |
| | 0.27 | 0.26 | 0.16 | 0.69 | 0.38 | 0.23 | 0.10 |
| 60–74 YO | |||||||
| SCP | 43.4 ± 1.4 | 17.9 ± 4.5 | 48.2 ± 1.5 | 47.1 ± 3.0 | 50.0 ± 3.5 | 46.5 ± 3.0 | 49.2 ± 3.2 |
| DCP | 43.8 ± 2.0 | 14.1 ± 4.3 | 49.4 ± 2.5 | 46.8 ± 3.6 | 50.9 ± 4.8 | 48.6 ± 3.8 | 51.3 ± 4.3 |
| | <0.001 | <0.001 | <0.001 | 0.56 | 0.19 | <0.001 | <0.01 |
SCP = superficial retinal capillary plexus, DCP = deep retinal capillary plexus, PD = perfusion density.
Spearman’s rank correlation coefficient between OCTA and clinical parameters.
| Overall SCP PD | Parafoveal SCP PD | Overall DCP PD | Parafoveal DCP PD | FAZ | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Correlation coefficient | Correlation coefficient | Correlation coefficient | Correlation coefficient | Correlation coefficient | ||||||
| Age (years) | −0.17 | 0.04 | −0.02 | 0.78 | −0.2 | 0.02 | −0.12 | 0.14 | 0.18 | 0.03 |
| SBP (mmHg) | −0.06 | 0.44 | −0.02 | 0.8 | −0.15 | 0.07 | −0.13 | 0.11 | −0.01 | 0.99 |
| DBP (mmHg) | −0.06 | 0.44 | −0.07 | 0.39 | −0.16 | 0.06 | −0.17 | 0.04 | −0.08 | 0.33 |
| TG (mg/dl) | 0.02 | 0.82 | −0.01 | 0.95 | −0.17 | 0.05 | −0.23 | 0.01 | −0.16 | 0.05 |
| AST (IU/L) | −0.02 | 0.83 | −0.02 | 0.77 | −0.09 | 0.27 | −0.07 | 0.41 | −0.03 | 0.71 |
| ALT (IU/L) | 0.03 | 0.69 | −0.01 | 0.97 | −0.03 | 0.76 | −0.02 | 0.78 | −0.12 | 0.15 |
| γ-GTP (IU/L) | 0.05 | 0.51 | 0.04 | 0.62 | −0.02 | 0.79 | −0.03 | 0.71 | −0.06 | 0.50 |
| eGFR (ml/min/1.73 m²) | 0.17 | 0.03 | 0.10 | 0.22 | 0.24 | <0.01 | 0.18 | 0.03 | −0.07 | 0.40 |
| HbA1c (%) | −0.18 | 0.03 | −0.13 | 0.12 | −0.11 | 0.19 | −0.08 | 0.35 | −0.07 | 0.37 |
| IOP (mmHg) | 0.02 | 0.82 | −0.02 | 0.82 | −0.04 | 0.66 | −0.07 | 0.41 | −0.03 | 0.70 |
| CMT (μm) | 0.15 | 0.08 | −0.01 | 0.89 | 0.08 | 0.35 | −0.01 | 1.00 | −0.39 | <0.001 |
| Overall SCP PD (%) | — | — | 0.87 | <0.001 | 0.67 | <0.001 | 0.59 | <0.001 | −0.18 | 0.03 |
| Overall DCP PD (%) | 0.67 | <0.001 | 0.51 | <0.001 | — | — | 0.94 | <0.001 | −0.25 | <0.01 |
| Parafoveal SCP PD (%) | 0.87 | <0.001 | — | — | 0.51 | <0.001 | 0.57 | <0.001 | 0.22 | <0.01 |
| Parafoveal DCP PD (%) | 0.59 | <0.001 | 0.57 | <0.001 | 0.94 | <0.001 | — | — | −0.03 | 0.72 |
| FAZ (mm²) | −0.18 | 0.03 | 0.22 | 0.01 | −0.25 | <0.01 | −0.03 | 0.72 | — | — |
PD = perfusion density, IOP = intraocular pressure, SBP = systolic blood pressure, DBP = diastolic blood pressure, TG = triglyceride, AST = aspartate aminotransferase, ALT = alanine aminotransferase, γ-GTP = γ-glutamyl transpeptidase, eGFR = glomerular filtration rate, HbA1c = hemoglobin A1c, CMT = central macular thickness, SCP = superficial retinal capillary plexus, DCP = deep retinal capillary plexus, FAZ = foveal avascular zone.
Figure 3Relationship between SCP PD, DCP PD and FAZ. Left: SCP PD was correlated with DCP PD (r = 0.67, P < 0.001). Right: SCP and DCP PD were correlated with FAZ area (r = −0.18, P = 0.03 and r = −0.25, P < 0.01, respectively).
Figure 4Association of CMT with SCP PD, DCP PD and FAZ. Left: SCP and DCP PD were not correlated with CMT (r = 0.15, P = 0.08 and r = 0.08, P = 0.35, respectively). Right: FAZ was correlated with CMT (r = −0.39, P < 0.001).
Multiple regression analysis of factors independently contributing to OCTA parameters.
| Dependent | Independent | β | |
|---|---|---|---|
| Variable | |||
| SCP PD | Age (years) | −0.14 | 0.16 |
| IOP (mmHg) | 0.01 | 0.94 | |
| SBP (mmHg) | 0.08 | 0.41 | |
| HbA1c (%) | −0.15 | 0.14 | |
| CMT (μm) | 0.13 | 0.12 | |
| DCP PD | Age (years) | −0.23 | 0.02 |
| IOP (mmHg) | −0.02 | 0.81 | |
| SBP (mmHg) | −0.07 | 0.50 | |
| HbA1c (%) | 0.01 | 0.91 | |
| CMT (μm) | 0.06 | 0.46 | |
| FAZ | Age (years) | 0.31 | <0.01 |
| IOP (mmHg) | 0.01 | 1.00 | |
| SBP (mmHg) | −0.15 | 0.11 | |
| HbA1c (%) | −0.16 | 0.08 | |
| CMT (μm) | −0.31 | <0.001 | |
PD = perfusion density, IOP = intraocular pressure, SBP = systolic blood pressure, HbA1c = hemoglobin A1c, CMT = central macular thickness, SCP = superficial retinal capillary plexus, DCP = deep retinal capillary plexus, FAZ = foveal avascular zone.
β = standard partial regression coefficient.
Characteristics of eyes divided by age and sex.
| All | All subjects 30–74 YO | 30–59 YO (N = 74) | 60–74 YO (N = 71) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | Male | Female | Male | Female | |||||
|
| ||||||||||
| Number of eyes | 145 | 45 | 100 | — | 21 | 53 | — | 24 | 47 | 0.48a |
| Age (years) | 53.3 ± 14.6 | 55.1 ± 13.6 | 51.7 ± 14.9 | 0.19 | 42.5 ± 8.6 | 39.1 ± 8.3 | 0.13 | 66.2 ± 4.2 | 65.9 ± 3.3 | 0.75 |
|
| ||||||||||
| SBP (mmHg) | 121.7 ± 15.4 | 124.1 ± 12.9 | 120.2 ± 16.4 | 0.16 | 122.6 ± 13.0 | 111.8 ± 12.5 | <0.01 | 125.4 ± 13.0 | 129.7 ± 15.0 | 0.23 |
| DBP (mmHg) | 72.9 ± 10.6 | 77.5 ± 10.4 | 70.6 ± 10.1 | <0.001 | 76.7 ± 11.6 | 68.3 ± 9.4 | <0.01 | 78.3 ± 9.5 | 73.2 ± 10.4 | 0.05 |
| TG (mg/dl) | 109.5 ± 65.0 | 145.6 ± 75.1 | 93.3 ± 53.3 | <0.001 | 142.7 ± 74.1 | 78.9 ± 53.6 | <0.001 | 148.1 ± 77.4 | 109.6 ± 48.5 | 0.01 |
| AST (IU/L) | 22.0 ± 6.3 | 24.6 ± 6.6 | 20.8 ± 5.9 | <0.001 | 25.2 ± 8.2 | 18.8 ± 4.4 | <0.001 | 24.1 ± 4.8 | 23.0 ± 6.6 | 0.49 |
| ALT (IU/L) | 19.5 ± 9.7 | 24.6 ± 11.7 | 17.2 ± 7.7 | <0.001 | 27.9 ± 15.4 | 16.1 ± 8.0 | <0.001 | 21.7 ± 6.3 | 18.4 ± 7.4 | 0.07 |
| γ-GTP (IU/L) | 27.9 ± 28.1 | 46.4 ± 43.0 | 19.6 ± 10.2 | <0.001 | 51.8 ± 51.4 | 17.5 ± 9.4 | <0.001 | 41.7 ± 34.5 | 21.9 ± 10.7 | <0.001 |
| eGFR (ml/min/1.73 m²) | 82.0 ± 16.5 | 80.0 ± 15.0 | 82.9 ± 17.2 | 0.35 | 86.5 ± 15.0 | 91.4 ± 15.2 | 0.21 | 74.4 ± 12.7 | 73.3 ± 14.1 | 0.74 |
| HbA1c (%) | 5.7 ± 0.3 | 5.6 ± 0.3 | 5.7 ± 0.3 | 0.25 | 5.6 ± 0.3 | 5.5 ± 0.3 | 0.40 | 5.7 ± 0.3 | 5.9 ± 0.3 | <0.01 |
|
| ||||||||||
| Axial length (mm) | 23.9 ± 1.1 | 24.0 ± 0.8 | 23.8 ± 1.2 | 0.25 | 24.3 ± 0.7 | 24.4 ± 1.1 | 0.79 | 23.8 ± 0.8 | 23.2 ± 0.9 | 0.01 |
| IOP (mmHg) | 13.8 ± 2.2 | 13.5 ± 2.4 | 13.8 ± 2.1 | 0.37 | 14.0 ± 2.6 | 13.9 ± 2.1 | 0.90 | 13.0 ± 2.3 | 13.8 ± 2.1 | 0.20 |
| CMT (μm) | 295.4 ± 16.5 | 305.1 ± 13.3 | 291.0 ± 16.1 | <0.001 | 308.1 ± 11.7 | 291.9 ± 17.0 | <0.001 | 302.5 ± 14.3 | 289.9 ± 15.0 | <0.01 |
| Overall SCP PD (%) | 43.6 ± 1.6 | 43.7 ± 1.3 | 43.6 ± 1.7 | 0.82 | 43.9 ± 1.1 | 43.8 ± 1.9 | 0.84 | 43.4 ± 1.4 | 43.3 ± 1.4 | 0.77 |
| Foveal SCP PD (%) | 19.4 ± 4.8 | 20.4 ± 4.7 | 18.9 ± 4.8 | 0.07 | 22.5 ± 4.9 | 20.1 ± 4.6 | 0.05 | 18.7 ± 3.8 | 17.5 ± 4.8 | 0.30 |
| Parafoveal SCP PD (%) | 48.2 ± 1.7 | 48.1 ± 1.6 | 48.3 ± 1.8 | 0.48 | 48.0 ± 1.8 | 48.4 ± 2.0 | 0.49 | 48.1 ± 1.4 | 48.2 ± 1.5 | 0.80 |
| Overall DCP PD (%) | 44.4 ± 2.2 | 44.1 ± 2.2 | 44.6 ± 2.2 | 0.19 | 44.9 ± 2.3 | 45.2 ± 2.1 | 0.58 | 43.4 ± 2.0 | 43.9 ± 2.0 | 0.28 |
| Foveal DCP PD (%) | 15.50 ± 4.7 | 16.7 ± 4.8 | 15.0 ± 4.6 | 0.05 | 18.2 ± 4.6 | 16.4 ± 4.6 | 0.13 | 15.3 ± 4.6 | 13.5 ± 4.1 | 0.09 |
| Parafoveal DCP PD (%) | 50.0 ± 2.6 | 49.3 ± 2.9 | 50.2 ± 2.4 | 0.05 | 50.0 ± 3.1 | 50.7 ± 2.5 | 0.30 | 48.7 ± 2.7 | 49.8 ± 2.3 | 0.10 |
| FAZ (mm²) | 0.37 ± 0.1 | 0.33 ± 0.12 | 0.38 ± 0.12 | 0.01 | 0.28 ± 0.12 | 0.36 ± 0.10 | <0.01 | 0.37 ± 0.11 | 0.41 ± 0.14 | 0.23 |
SBP = systolic blood pressure, DBP = diastolic blood pressure, TG = triglyceride, AST = aspartate aminotransferase, ALT = alanine aminotransferase, γ-GTP = γ-glutamyl transpeptidase, eGFR = glomerular filtration rate, HbA1c = hemoglobin A1c, IOP = intraocular pressure, CMT = central macular thickness, SCP = superficial retinal capillary plexus, PD = perfusion density, DCP = deep retinal capillary plexus, FAZ = foveal avascular zone.
aChi-square test.